{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:07:09Z","timestamp":1773299229970,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":5643,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1538-7836.2007.02494.x","type":"journal-article","created":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T11:57:52Z","timestamp":1183982272000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects"],"prefix":"10.1016","volume":"5","author":[{"given":"P.A.","family":"KOUIDES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"KADIR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/asheducation-2006.1.474","article-title":"Bleeding disorders in premenopausal women: (another) public health crisis for hematology?","author":"James","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1471-0528.1992.tb13758.x","article-title":"The epidemiology of hysterectomy: findings in a large cohort study","volume":"99","author":"Vessey","year":"1992","journal-title":"Br J Obst Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1034\/j.1600-0412.2003.00097.x","article-title":"Menorrhagia: an update","volume":"82","author":"Oehler","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0025","unstructured":"Shaw JA, Shaw HA. Menorrhagia. http:\/\/www.emedicine.com\/med\/topic1449.htm\/"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0030","first-page":"64","article-title":"Menorrhagia management options","volume":"64","author":"Doherty","year":"1995","journal-title":"Ulster Med J"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.1999.00719.x","article-title":"Disturbances of menstruation in hypothyroidism","volume":"50","author":"Krassas","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.294.6574.759","volume":"294","author":"Rees","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of menstrual blood loss","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.AOG.0000133487.55682.7b","article-title":"Testing for von Willebrand disease in women with menorrhagia: a systematic review","volume":"104","author":"James","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0055","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.2004.00176.x","article-title":"von Willebrand disease in women with menorrhagia: a systematic review","volume":"111","author":"Shankar","year":"2004","journal-title":"Br J Obst Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2516.1999.00285.x","article-title":"Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders","volume":"5","author":"Kadir","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<48::AID-AJH8>3.0.CO;2-Q","article-title":"Factor XI deficiency in women","volume":"60","author":"Kadir","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1749-6632.1992.tb51629.x","article-title":"Menstruation: extravascular fibrinolytic activity and reduced fibrinolytic capacity","volume":"667","author":"Winkler","year":"1992","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00001721-200309000-00012","article-title":"On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin","volume":"14","author":"Edlund","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00001721-200204000-00008","article-title":"Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time","volume":"13","author":"Edlund","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1538-7836.2003.00061.x","article-title":"Platelet functional defects in women with unexplained menorrhagia","volume":"1","author":"Philipp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0090","unstructured":"Miller CH, Heit J, Kouides PA, Lukes A, Philipp CS, Stein FS, Dowling N, Byams VR, Rawlins P.R., Kulkarni R. Laboratory characteristics of women with menorrhagia: a multi-site U.S. study. J Haemost Thromb, (in press)."},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0095","first-page":"1056","article-title":"Platelet dysfunction and other hemostatic abnormalities in iron deficient women with unexplained menorrhagia","volume":"98","author":"Gulbas","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0100","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0105","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2007.02494.x_bb0110","first-page":"S101","volume":"1","author":"Chi","year":"2007","journal-title":"Bleeding score as screening tool for the identification and assessment of von Willebrand disease in women; Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0115","first-page":"1025","volume":"108","author":"Philipp","year":"2007","journal-title":"Development of a screening tool in women presenting with unexplained menorrhagia; Blood"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/jwh.1.1999.8.443","article-title":"von Willebrand disease in women: the need for recognition and understanding","volume":"8","author":"Dilley","year":"1999","journal-title":"J Womens Health Gender Med"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1160\/TH04-10-0670","article-title":"Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association","volume":"93","author":"Moffat","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.2830400208","article-title":"On laboratory problems in diagnosing mild von Willebrand\u2019s disease","volume":"40","author":"Blomback","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0038-1648383","article-title":"On the intraindividual and gender variability of haemostatic components","volume":"67","author":"Blomback","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0038-1646899","article-title":"Changes in plasma coagulation and fibrinolysis in response to mental stress","volume":"62","author":"Jern","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0049-3848(72)90056-4","article-title":"Rise of Factor VIII after exercise and adrenaline infusion, measured by immunological and biological techniques","volume":"1","author":"Prentice","year":"1972","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<234::AID-AJH4>3.0.CO;2-Z","article-title":"On the value of menorrhagia as a predictor for coagulation disorders","volume":"53","author":"Edlund","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)08248-2","article-title":"Frequency of inherited bleeding disorders in women with menorrhagia","volume":"351","author":"Kadir","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0160","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0037-1612925","article-title":"Von Willebrand factor does not vary during the normal menstrual cycle [letter]","volume":"85","author":"Onundarson","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0170","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/s-0037-1613140","article-title":"Changes in von Willebrand factor and Factor VIII levels during the menstrual cycle [letter]","volume":"87","author":"Miller","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0175","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand\u2019s disease: variability versus \u2018variants\u2019","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-9343(82)90729-X","article-title":"Estrogens and surgery in women with von Willebrand\u2019s disease","volume":"73","author":"Alperin","year":"1982","journal-title":"Am J Medicine"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0185","first-page":"1274","article-title":"Oral contraceptives and von Willebrand\u2019s disease [letter]","volume":"128","author":"Mangal","year":"1983","journal-title":"Can Med Assoc J"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00001721-199404000-00008","article-title":"Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation?","volume":"5","author":"Bremme","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001721-200112000-00009","article-title":"Hypercoagulation in surgical postmenopausal women having hormone replacement with overdose estradiol","volume":"12","author":"He","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrands disease or Factor XI deficiency","volume":"105","author":"Kadir","year":"1998","journal-title":"Br J Obst Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jcp.47.6.569-b","article-title":"Pregnancy in von Willebrand\u2019s disease [letter; comment]","volume":"47","author":"Ramsahoye","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/107602969900500112","article-title":"Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel","volume":"5","author":"Prasad","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0215","first-page":"725","article-title":"Influence of triphasic oral contraceptives on blood rheology and hemostatic and metabolic patterns in young women. Results of a three-year study","volume":"37","author":"Solerte","year":"1992","journal-title":"J Reprod Med"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0220","first-page":"631","article-title":"Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems","volume":"109","author":"Gevers Leuven","year":"1987","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0225","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0015-0282(02)04285-1","article-title":"Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women","volume":"78","author":"Hall","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9378(90)90594-W","article-title":"Hemostasis profile in women taking low-dose oral contraceptives","volume":"163","author":"David","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/107602960100700206","article-title":"Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine","volume":"7","author":"Michiels","year":"2001","journal-title":"Clin Applied Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders \u2013 review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors\u2019 Organization","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijgo.2006.02.004","article-title":"Gynaecological and obstetric management of women with inherited bleeding disorders","volume":"95","author":"Demers","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0250","unstructured":"Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. Von Willebrand Disease Guidelines www.nhlbi.nih.gov\/guidelines\/vwd."},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2006.02243.x","article-title":"The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the haemostatic, fibrinolytic\/inhibitor systems in women with menorrhagia","volume":"5","author":"Koh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0260","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1471-0528.1976.tb00784.x","article-title":"Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss","volume":"83","author":"Hahn","year":"1976","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0265","unstructured":"Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2007; 2."},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0270","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1471-0528.1995.tb10881.x","article-title":"Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161)","volume":"102","author":"Edlund","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bmj.4.5729.214","article-title":"Treatment of menorrhagia with tranexamic acid. A double-blind trial","volume":"4","author":"Callender","year":"1970","journal-title":"Br Med J"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2516.1998.00147.x","article-title":"Menorrhagia in von-Willebrand disease successfully treated with single daily dose tranexamic acid","volume":"4","author":"Ong","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2516.1999.00286.x","article-title":"Treatment of menorrhagia in von Willebrand\u2019s disease [letter]","volume":"5","author":"Onundarson","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0290","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2516.1999.00313.x","article-title":"Desmopressin in the treatment of women\u2019s bleeding disorders","volume":"5","author":"Lethagen","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0300","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2516.2001.00500.x","article-title":"High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A","volume":"7","author":"Leissinger","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0305","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2516.2002.00678.x","article-title":"DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study","volume":"8","author":"Kadir","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0310","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0029-7844(95)00062-V","article-title":"A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss","volume":"85","author":"Janssen","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0315","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0015-0282(16)36070-8","article-title":"Menstruation in women with normal or artificially controlled cycles","volume":"17","author":"Callard","year":"1966","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0320","first-page":"345","article-title":"The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: a comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives","volume":"25","author":"Ramcharan","year":"1980","journal-title":"J Reprod Med"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0325","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0002-9378(71)90259-6","article-title":"Treatment of menorrhagia","volume":"110","author":"Nilsson","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0330","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/s-0038-1649813","article-title":"The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH","volume":"74","author":"Foster","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0335","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2516.2000.00447.x","article-title":"Gynecological and obstetrical morbidity in women with Type I von Willebrand disease: results of a patient survey","volume":"6","author":"Kouides","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0340","first-page":"t","article-title":"Type I von Willebrand\u2019s disease presenting as recurrent corpus hemorrhagicum","volume":"99","author":"Jarvis","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.1994.tb13687.x","article-title":"Treating the patient with menorrhagia","volume":"10","author":"Shaw","year":"1994","journal-title":"Br J Obst Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0350","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1471-0528.2001.00020.x","article-title":"The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review","volume":"108","author":"Stewart","year":"2001","journal-title":"Br J Obst Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0355","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up [see comment]","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0360","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of Levonorgestrel-releasing intrauterine system for the treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02494.x_bb0365","first-page":"S101","article-title":"Levonorgestrel-releasing intrauterine system for the management of menorrhagia in women with inherited bleeding disorders: long term follow-up","volume":"00","author":"Chi","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0370","first-page":"146","article-title":"The efficacy and safety of the levonorgestrel device (MIRENA\u2122) for bleeding disorder-related menorrhagia in an American cohort","volume":"12","author":"Kouides","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0375","article-title":"Advantages with Using the Levonorgestrel-Releasing Intrauterine System in Females with Hemostatic Disorders","volume":"108","author":"Lukes","year":"2006"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0380","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/01.AOG.0000157758.94890.59","article-title":"von Willebrand\u2019s disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system","volume":"105","author":"Lukes","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0385","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2516.2003.00756.x","article-title":"Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand\u2019s disease receiving care in haemophilia treatment centres: a case\u2013control study","volume":"9","author":"Kirtava","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0390","unstructured":"Howard F, Phatak P, Braggins C, Cox C, Kouides PA. Patient preferences\/outcomes for the treatment of menorrhagia from a prospective study of the prevalence of von Willebrand disease-related menorrhagia; Haemophilia 2000; 6: 242 [abstract]."},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0395","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1471-0528.2002.01282.x","article-title":"The VALUE national hysterectomy study: description of the patients and their surgery","volume":"109","author":"Maresh","year":"2002","journal-title":"Br J Obst Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0400","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2516.2004.00915.x","article-title":"Endometrial ablation for von Willebrand disease-related menorrhagia \u2013 experience with seven cases","volume":"10","author":"Rubin","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02494.x_bb0405","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0015-0282(01)01847-7","article-title":"Determination of total menstrual blood loss","volume":"76","author":"Wyatt","year":"2001","journal-title":"Fertil Steril"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02494.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02494.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:43:14Z","timestamp":1761532994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622175847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":80,"alternative-id":["S1538783622175847"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02494.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02494.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}